SCHEMBL5465698

SCHEMBL5465698

COCCn1c(N)nc2cccc(Cl)c21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.59
HTT P42858 2/20 0.50
TP53 P04637 1/20 0.50
KMT2A Q03164 1/20 0.50
TLR8 Q9NR97 1/20 0.47
CASR P41180 4/20 0.46
NOD1 Q9Y239 2/20 0.44
CXCL8 P10145 1/20 0.44
TNF P01375 1/20 0.43
NOD2 Q9HC29 1/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
PSMB8 P28062 1/20 0.41
POLB P06746 1/20 0.40
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456433 0.92 PRMT5 (0.56) PRMT5HTTTP53KMT2ATLR8
SCHEMBL5456471 0.82 NOD1 (0.60) PRMT5HTTTP53KMT2ANOD1
SCHEMBL5463793 0.82 TLR8 (0.49) PRMT5HTTKMT2ATLR8CASR
SCHEMBL5453935 0.81 TLR8 (0.66) PRMT5HTTTLR8NOD1TNF
SCHEMBL5463706 0.80 PRMT5 (0.63) PRMT5HTTTP53KMT2ATLR8
SCHEMBL5141398 0.78 PRMT5 (0.56) PRMT5HTTTP53KMT2ATLR8
SCHEMBL15595665 0.76 POLB (0.69) HTTTP53KMT2ATLR8CASR
SCHEMBL5104145 0.75 PRMT5 (1.00) PRMT5HTTTP53KMT2ATLR8
SCHEMBL5453997 0.74 TLR8 (0.53) KMT2ATLR8ALDH1A1LMNAHPGD
SCHEMBL16084470 0.72 CDK9 (0.41) HTTTP53KMT2ANOD1CXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 PRMT5 2145/4885HTT 4363/4885TP53 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.